PatenSee
PrivateLast Round
Seed
Feb 20, 2025
Total Funding Raised
$2.75M
Momentum Score
25 /100
Company Overview
PatenSee is a medical devices company developing a non-contact monitoring system for the early detection of vascular access stenosis in hemodialysis patients using advanced, multi-modal imaging technologies and AI.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Medical Imaging, Clinical Trials, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PatenSee Comps
Public and private peers based on sector, stage, and business model.
PatenSee Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 20, 2025 | ||||
| Seed | May 18, 2021 |
PatenSee Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Paul Neeb, a seasoned early-stage CEO, will take over as CEO on January 1, 2026.
- Feb 20, 2025
Establishing US headquarters in Michigan to support clinical trials and commercial launch.
PatenSee Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PatenSee's valuation, stock price, and market status.
